Follow
InDex Pharmaceuticals Holding AB
Nasdaq First North GM (Sweden)
InDex Pharmaceuticals Holding AB is a pharmaceutical development company focusing on immunological diseases where there is an unmet medical need for new treatment options. Its portfolio includes cobitolimod and colitis.
Sector:
HEALTH CARE
>
Biotechnology
Healthcare
Instruments & Events
The shares and options available for this company. Including past events like IPOs, direct listings and exercise periods.
Type
Ticker
ISIN
Market
SHARE
INDEX
SE0008966295
Nasdaq First North GM
Sweden (SE)
Details of share in InDex Pharmaceuticals Holding AB with ticker INDEX
Status
Active
Order book id
Amount of instruments
532 687 650
Par value
0.0200
Currency
SEK
Segment
First North
First trading date
11 Oct 2016
Type
Price
Pre-money
Time
Files
IPO
8.40 SEK
274.69M SEK
14 Sep - 27 Sep 2016
IPO in InDex Pharmaceuticals Holding AB
Type
Price
Pre-money
Time
Files
Directed issue
6.02 SEK
376.42M SEK
23 Oct 2018
Share issue in InDex Pharmaceuticals Holding AB
Type
Price
Pre-money
Time
Files
Directed issue
6.98 SEK
480.09M SEK
19 Sep - 20 Sep 2019
Share issue in InDex Pharmaceuticals Holding AB
Type
Price
Pre-money
Time
Files
Rights issue
1.20 SEK
106.54M SEK
22 Jan - 05 Feb 2021
Share issue in InDex Pharmaceuticals Holding AB
People
Peter Zerhouni
CEO
Wenche Rolfsen
Chairman of the board
Marlene Forsell
Board member
Uli Hacksell
Board member
Lennart Hansson
Board member
Yilmaz Mahshid
Board member
Stig Lökke Pedersen
Board member
Company Details
Sector
HEALTH CARE

Address
Tomtebodavägen 23 A
Zip code
171 65
City/district
Solna
Country
Sweden (SE)
Registration number
559067-6820
LEI code
54930047C4A74IBXR037
First trade date
11 Oct 2016
Registration date
25 May 2006
Short name
InDex Pharma

We use cookies to make your experience using IPOhub better. By using our site you agree to our use of cookies. Learn More